Bioactivity:

Eslicarbazepine acetate (ESL) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

CAS nr:

236395-14-5

Purity:

98%

Molecular Weight:

296,32

SMILES:

c12c(cccc1)N(c1ccccc1C[C@@H]2OC(=O)C)C(=O)N

Formula:

C17H16N2O3

Pathway:

Membrane transporter/Ion channel,Neuroscience

Target:

Sodium Channel,Beta-Secretase